7238-1237 Screening compound: 6-(4-methoxyphenyl)-3-methyl-N-[(oxolan-2-yl)methyl]-5H,6H,7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-carboxamide

7238-1237 Screening compound: 6-(4-methoxyphenyl)-3-methyl-N-[(oxolan-2-yl)methyl]-5H,6H,7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-carboxamide
7238-1237 Screening compound: 6-(4-methoxyphenyl)-3-methyl-N-[(oxolan-2-yl)methyl]-5H,6H,7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 7238-1237
6-(4-methoxyphenyl)-3-methyl-N-[(oxolan-2-yl)methyl]-5H,6H,7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

7238-1237

Molecular Formula

C18H23N5O3S (C18 H23 N5 O3 S)

Compound Name

6-(4-methoxyphenyl)-3-methyl-N-[(oxolan-2-yl)methyl]-5H,6H,7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-7-carboxamide

IUPAC name

6-(4-methoxyphenyl)-3-methyl-N-[(oxolan-2-yl)methyl]-5H6H7H-[124]triazolo[34-b][134]thiadiazine-7-carboxamide

SMILES

Cc(n1NC2c(cc3)ccc3OC)nnc1SC2C(NCC1OCCC1)=O

InChI

InChI=1S/C18H23N5O3S/c1-11-20-21-18-23(11)22-15(12-5-7-13(25-2)8-6-12)16(27-18)17(24)19-10-14-4-3-9-26-14/h5-8,14-16,22H,3-4,9-10H2,1-2H3,(H,19,24)

InChI Key

HVBIWQZZDJWPTD-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14712453

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

389.48

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

0.976

Distribution Coefficient, logD

0.976

Water Solubility, LogSw

-2.03

Polar Surface Area

78.352

Acid Dissociation Constant (pKa)

13.35

Base Dissociation Constant (pKb)

1.00

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

50.00

7238-1237 in Drug Discovery

Included in Screening Libraries

KRAS-Targeted Library (16000 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 7238-1237 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 7238-1237?
Check Price and Availability of 7238-1237, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 7238-1237 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 7238-1237
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 7238-1237
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 7238-1237 available by request